DRUGS & AGING

Scope & Guideline

Exploring effective medications to support aging populations.

Introduction

Delve into the academic richness of DRUGS & AGING with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1170-229x
PublisherADIS INT LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1991 to 2024
AbbreviationDRUG AGING / Drugs Aging
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND

Aims and Scopes

The journal 'DRUGS & AGING' aims to address the complex pharmacotherapy needs of older adults, focusing on optimizing medication use while minimizing potential adverse effects. Its scope encompasses various aspects of drug therapy in geriatric populations, emphasizing evidence-based practices and interdisciplinary approaches.
  1. Geriatric Pharmacotherapy:
    Research dedicated to understanding the pharmacokinetics and pharmacodynamics of drugs in older adults, including how aging affects drug metabolism and response.
  2. Polypharmacy and Deprescribing:
    Focused studies on the prevalence and effects of polypharmacy in older adults, including strategies for deprescribing potentially inappropriate medications to improve patient outcomes.
  3. Chronic Disease Management:
    Investigations into the management of chronic conditions prevalent among older adults, such as diabetes, hypertension, and cardiovascular diseases, with an emphasis on tailored pharmacological interventions.
  4. Adverse Drug Reactions and Drug Interactions:
    Research aimed at identifying and mitigating adverse drug reactions and interactions, especially in the context of multimorbidity and polypharmacy.
  5. Quality of Life and Patient-Centered Care:
    Studies that explore the impact of pharmacotherapy on the quality of life, emphasizing patient perspectives and outcomes in the context of aging.
  6. Innovative Therapeutics:
    Research into newer therapeutic agents and treatment modalities, including biologics and targeted therapies, specifically for older populations.
The landscape of research within 'DRUGS & AGING' is dynamic, with several emerging themes reflecting current clinical challenges and innovations in geriatric pharmacotherapy.
  1. Digital Health and Telemedicine:
    An increasing number of studies are focusing on the role of digital tools and telemedicine in managing medications and health outcomes for older adults, highlighting the need for innovative approaches in a rapidly changing healthcare environment.
  2. Patient-Reported Outcomes and Quality of Life:
    There is a growing emphasis on incorporating patient-reported outcomes in research, reflecting a trend towards more holistic approaches to treatment that prioritize the patient's perspective on their health and medication.
  3. Pharmacogenomics in Aging:
    Emerging interest in pharmacogenomic studies to personalize medication regimens for older adults, aiming to optimize therapeutic efficacy while minimizing adverse effects.
  4. Use of Cannabis and Cannabinoids:
    Research on the use of medical cannabis and cannabinoids among older adults is gaining traction, particularly in relation to pain management and quality of life improvements.
  5. Focus on Frailty and Comprehensive Geriatric Assessment:
    An increasing number of studies are honing in on frailty as a critical factor in medication management, advocating for comprehensive geriatric assessments to tailor pharmacological treatments.

Declining or Waning

As the journal 'DRUGS & AGING' evolves, certain research themes appear to be declining in prominence. This may reflect shifts in clinical priorities, emerging evidence, or changing healthcare landscapes affecting older adults.
  1. Anticholinergic Burden Studies:
    While still relevant, there has been a noticeable decrease in dedicated studies focusing solely on anticholinergic burden, suggesting a potential shift towards broader polypharmacy and deprescribing discussions.
  2. Traditional Pain Management Approaches:
    Research centered around traditional pain management strategies, particularly opioid use, has seen reduced focus, likely due to increasing scrutiny over opioid prescribing and a shift towards non-pharmacological management.
  3. Longitudinal Studies of Aging and Medication Use:
    Fewer long-term studies tracking medication use and outcomes in aging populations indicate a potential waning interest in longitudinal methodologies in favor of more immediate, intervention-focused research.

Similar Journals

Geriatrie et Psychologie Neuropsychiatrie du Vieillissement

Fostering Collaboration for Improved Geriatric Outcomes
Publisher: JOHN LIBBEY EUROTEXT LTDISSN: 2115-8789Frequency: 4 issues/year

Geriatrie et Psychologie Neuropsychiatrie du Vieillissement is a pivotal academic journal dedicated to the multidisciplinary study of aging, encompassing the fields of geriatrics, neuropsychiatry, and psychological health in the elderly population. Published by JOHN LIBBEY EUROTEXT LTD, this journal fosters knowledge dissemination and innovation, contributing to the understanding of the complexities faced by aging individuals. With a broad scope that includes biological psychiatry and neuropsychology, it serves as a vital resource for researchers, healthcare professionals, and students engaged in geriatric medicine and mental health. Although currently classified in the Q4 category across various relevant medical and psychological disciplines, the journal addresses critical topics that are essential for enhancing quality of care and improving patient outcomes. Additionally, the journal is accessible via open access options, promoting wide-ranging readership and collaboration within the academic community. As the field continuously evolves, Geriatrie et Psychologie Neuropsychiatrie du Vieillissement remains commited to pushing the boundaries of research and practice in gerontology and neuropsychiatry.

ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE

Innovating research for healthier ageing.
Publisher: SPRINGER HEIDELBERGISSN: 0948-6704Frequency: 8 issues/year

ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, published by SPRINGER HEIDELBERG, is an authoritative journal dedicated to advancing the field of geriatrics and gerontology. With its ISSN 0948-6704 and E-ISSN 1435-1269, this journal has been a significant source of scholarly articles since its inception in 1995, catering to researchers and practitioners amid the growing importance of ageing studies. While it currently holds a Q4 ranking in Geriatrics and Gerontology and a Q3 ranking in Gerontology and Social Sciences, its contribution spans vital topics related to health ethics and legal aspects—reflecting a comprehensive view of the challenges faced in elder care. Although it is not an open-access journal, its rigorous peer-review process ensures that the research published is of high quality and relevance. Based in Heidelberg, Germany, the journal aims to foster discourse and disseminate crucial research findings that impact the health of elderly populations, making it an essential resource for researchers, healthcare professionals, and students devoted to improving geriatric care and understanding the complexities associated with ageing.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Fostering Insights in Pharmacology and Toxicology for Better Health
Publisher: WILEYISSN: 1742-7835Frequency: 12 issues/year

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, published by WILEY, serves as a vital resource in the fields of medicine, pharmacology, and toxicology. With an ISSN of 1742-7835 and E-ISSN 1742-7843, this journal has established a robust reputation, reflected in its Q2 classification across its categories in 2023. It aims to disseminate high-quality research and reviews that bridge the gap between basic scientific findings and clinical applications. Operating from the United States with an address at 111 RIVER ST, HOBOKEN 07030-5774, NJ, this journal focuses on the intersection of drug action and toxicity, making it an essential platform for researchers, healthcare professionals, and students. With a converged publication timeline from 2004 to 2024, BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY continues to make significant contributions to understanding pharmacological treatments and toxicological challenges. Open access options are available to broaden the reach and impact of its published work.

Canadian Geriatrics Journal

Advancing geriatric knowledge for a healthier tomorrow.
Publisher: MULTIMED INCISSN: Frequency: 4 issues/year

Canadian Geriatrics Journal, published by MULTIMED INC, is a prominent platform dedicated to advancing the field of geriatrics and gerontology. With its esteemed status as a Q2 journal in both Geriatrics and Gerontology categories for 2023, it ranks favorably within the academic community, holding a 73rd percentile in Nursing Gerontology and a 59th percentile in Medicine Geriatrics and Gerontology according to Scopus metrics. Since its inception in 2011, the journal has aimed to foster innovation and disseminate pivotal research that addresses the complexities of aging populations. Researchers, healthcare professionals, and students interested in the intricacies of geriatric care will find a wealth of open-access resources that contribute significantly to enhancing practice and care methodologies in Canada and beyond. With its address located at 66 Martin St, Toronto, ON L9T 2R2, Canada, the journal stands as a vital resource for stakeholders in the geriatric field.

AGE AND AGEING

Unraveling the Complexities of Age
Publisher: OXFORD UNIV PRESSISSN: 0002-0729Frequency: 6 issues/year

AGE AND AGEING is a premier peer-reviewed journal published by Oxford University Press, dedicated to advancing the field of gerontology and related medical disciplines. With its ISSN of 0002-0729 and E-ISSN 1468-2834, the journal has established itself as a critical platform for disseminating innovative research since its inception in 1972. It boasts impressive rankings within the Q1 category in Aging, Geriatrics and Gerontology, and Miscellaneous Medicine, reflecting its influential position in the scientific community. Researchers and practitioners alike value the journal's focus on the clinical, biological, and social aspects of aging, providing a multidisciplinary approach essential for addressing the challenges of an aging population. The journal maintains a significant impact factor, demonstrating its contribution to scholarly communication and knowledge dissemination. Although it does not operate under an open access model, AGE AND AGEING remains an essential resource for those committed to understanding the complexities of aging and enhancing the quality of life for older adults.

European Journal of Geriatrics and Gerontology

Advancing research in aging for a healthier tomorrow.
Publisher: GALENOS PUBL HOUSEISSN: 2687-2625Frequency: 3 issues/year

Welcome to the European Journal of Geriatrics and Gerontology, a peer-reviewed platform dedicated to advancing knowledge and research in the fields of geriatrics and gerontology. Published by GALENOS PUBL HOUSE, this journal serves as a critical resource for researchers, healthcare professionals, and students who are involved in the care, treatment, and study of elderly populations. Since its inception in 2019 and running through 2024, the journal aims to foster interdisciplinary collaboration and disseminate innovative research that addresses the unique challenges faced by older adults. With an ISSN of 2687-2625, the journal is classified in the Q4 quartile of the Geriatrics and Gerontology category, signifying its emerging influence within the academic community, despite its current Scopus ranking of #113 out of 116, reflecting a rich opportunity for growth and visibility. Although the journal is not open access, it maintains a commitment to scholarly rigor and quality. Engage with the European Journal of Geriatrics and Gerontology to contribute to and learn from the evolving discourse in aging research.

DRUGS & THERAPY PERSPECTIVES

Catalyzing Change in the World of Pharmacology and Therapy
Publisher: SPRINGERNATUREISSN: 1172-0360Frequency: 12 issues/year

DRUGS & THERAPY PERSPECTIVES is an esteemed journal published by SpringerNature, dedicated to advancing knowledge in the field of pharmacology and therapeutic studies. With an ISSN of 1172-0360 and an E-ISSN of 1179-1977, this journal has been providing valuable insights since its inception in 1993 and continues to publish until 2024. Ranked in the Q3 category for Pharmacology (medical) and positioned within the 25th percentile according to Scopus rankings, it serves as a vital resource for researchers, practitioners, and students alike. Although it is not an open-access journal, it offers a comprehensive platform for innovative research, clinical practices, and evolving therapeutic strategies, reflecting the critical developments in drug therapy landscape. With its strategic emphasis on bridging academic studies and clinical applications, DRUGS & THERAPY PERSPECTIVES remains essential for those committed to enhancing drug efficacy and patient outcomes in the ever-evolving medical field.

Advances in Gerontology

Fostering Insights into Aging Dynamics
Publisher: PLEIADES PUBLISHING INCISSN: 2079-0570Frequency: 4 issues/year

Advances in Gerontology is a pivotal academic journal dedicated to the field of gerontology, published by PLEIADES PUBLISHING INC. With its ISSN 2079-0570 and E-ISSN 2079-0589, this journal serves as an essential platform for researchers, healthcare professionals, and students focused on aging and related health issues. Although currently not an open-access journal, it aspires to enrich the scholarly community by disseminating high-quality research from 2011 through 2024. The journal is recognized in the lower quartile of its category, ranking Q4 in both Geriatrics and Gerontology, reflecting its commitment to addressing emerging topics in the aging population despite its lower visibility in the competitive landscape. As it continues to explore critical areas in gerontology, Advances in Gerontology invites contributions that advance knowledge, foster understanding, and inform practices within this essential field of study.

Journal of Frailty & Aging

Enhancing understanding of health in older adults.
Publisher: SPRINGER BASEL AGISSN: 2260-1341Frequency: 4 issues/year

Journal of Frailty & Aging, published by SPRINGER BASEL AG, is a leading platform dedicated to advancing research in the fields of aging, geriatrics, and gerontology. With an ISSN of 2260-1341 and an E-ISSN of 2273-4309, this journal has established itself as a pivotal resource for scholars and practitioners aiming to explore the complexities of frailty and its impact on aging populations. As of 2023, it proudly holds a Q3 classification in Aging and Q2 classifications in both Geriatrics and Gerontology, as well as Physiology (medical), alongside a notable Q1 ranking in Medicine (miscellaneous). The journal's Scopus ranks further reflect its quality and relevance, with rankings as high as #22 in Aging within the Biochemistry, Genetics and Molecular Biology category. The Journal of Frailty & Aging invites contributions that illuminate contemporary challenges and innovations in the field, offering Open Access to enhance the dissemination of knowledge. By publishing rigorous research and impactful reviews, the journal strives to foster a deeper understanding of health and well-being in older adults, making it an essential resource for researchers, healthcare professionals, and students engaged in this vital area of study.

Journal of Gerontology and Geriatrics

Transforming Perspectives on Geriatric Health
Publisher: PACINI EDITOREISSN: 2499-6564Frequency: 4 issues/year

Journal of Gerontology and Geriatrics, published by PACINI EDITORE, is a crucial resource for those dedicated to the study of aging and geriatric health. Since its inception in 2016, this journal has aimed to disseminate high-quality research and findings that address the intricate biological, social, and psychological aspects of aging. With ISSN 2499-6564 and E-ISSN 2499-6564, it strives to foster discussions that enhance our understanding of gerontology and geriatrics on a global scale, despite its current positioning in the Q4 quartile of academic rankings. Located in Pisa, Italy, the journal invites contributions from researchers, professionals, and students who are passionate about advancing knowledge in these critical fields. Although it currently does not offer open access, the journal plays a vital role in connecting the community with essential insights that guide both research and practice in geriatric care.